67083-23-2

Upstream product

• 67083-22-1 N-(2,6-dimethyl-4-nitrophenyl)-4-methylbenzenesulfonamide 
• 4703-15-5 N-(2,6-dimethylphenyl)-4-methylbenzenesulfonamide 
• 87-62-7 2,6-dimethylaniline 
• 16947-63-0 2,6-dimethyl-4-nitroaniline 
• 79-04-9 chloroacetyl chloride 

Downstream Products

• 67083-24-3 2-(diethylamino)-N-(2,6-dimethyl-4-nitrophenyl)acetamide 
• 83473-23-8 2-Dimethylamino-N-(2,6-dimethyl-4-nitro-phenyl)-acetamide 
• 83473-57-8 N-{4-[Butyl-(toluene-4-sulfonyl)-amino]-2,6-dimethyl-phenyl}-2-diethylamino-acetamide 
• 83473-43-2 2-Diethylamino-N-[2,6-dimethyl-4-(toluene-4-sulfonylamino)-phenyl]-acetamide 
• 83473-70-5 N-(4-Amino-2,6-dimethyl-phenyl)-2-dimethylamino-acetamide 
• 83473-84-1 N,N-diethyl-glycine-(4-butylamino-2,6-dimethyl-anilide) 
• 27951-88-8 N-(4-amino-2,6-dimethylphenyl)-2-(diethylamino)acetamide 

Relevant academic research and scientific papers

Method and using tracer charged ion channel

The invention provides compounds, compositions, methods, and kits for the treatment of pain, itch, and neurogenic inflammation.

Lidocaine antigens and antibodies

Derivatives of anesthetics involving anilides, lidocaine being illustrative, are provided, having an annular amino group. A difunctional linking group is provided, which provides a link to the annular amino group and an antigen, with the resulting conjugate being employed for the preparation of antibodies. The antibodies find particular use in competitive protein binding assays. Conjugates to enzymes are prepared which find particular use in homogeneous enzyme immunoassays.